Clinical data
Other names
M-2613; Methoxyethoxy-triphenylbromoethylene
Identifiers
1-Bromo-2-(p-ethoxyphenyl)-2-(p-methoxyphenyl)-1-phenylethylene
Chemical and physical data
C23H21BrO2
409.323 g·mol−1
M2613 is a nonsteroidal estrogen derived from triphenylbromoethylene which was studied for the treatment of breast cancer in women in the 1940s, but was never marketed.[1][2]
ERTooltip Estrogen receptor
Mixed
(SERMsTooltip Selective estrogen receptor modulators)
Antagonists
GPERTooltip G protein-coupled estrogen receptor
Antagonists
Unknown
This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.